Anatomy-based inverse optimization in high-dose-rate brachytherapy combined with hypofractionated external beam radiotherapy for localized prostate cancer: Comparison of incidence of acute genitourinary toxicity between anatomy-based inverse optimization and geometric optimization

被引:18
|
作者
Akimoto, T [1 ]
Katoh, H [1 ]
Kitamoto, Y [1 ]
Shirai, K [1 ]
Shioya, M [1 ]
Nakano, T [1 ]
机构
[1] Gunma Univ, Grad Sch Med, Dept Radiat Oncol, Maebashi, Gumma 3718511, Japan
关键词
high-close-rate brachytherapy; inverse optimization; hypofractionation; acute toxicity; prostate cancer;
D O I
10.1016/j.ijrobp.2005.10.005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To evaluate the advantages of anatomy-based inverse optimization (IO) in planning high-close-rate (HDR) brachytherapy. Methods and Materials: A total of 114 patients who received HDR brachytherapy (9 Gy in two fractions) combined with hypofractionated external beam radiotherapy (EBRT) were analyzed. The dose distributions of HDR brachytherapy were optimized using geometric optimization (GO) in 70 patients and by anatomy-based 10 in the remaining 44 patients. The correlation between the dose-volume histogram parameters, including the urethral dose and the incidence of acute genitourinary (GU) toxicity, was evaluated. Results: The averaged values of the percentage of volume receiving 80-150% of the prescribed minimal peripheral dose (V-80-V-150) of the urethra generated by anatomy-based 10 were significantly lower than the corresponding values generated by GO. Similarly, the averaged values of the minimal dose received by 5-50% of the target volume (D-5-D-50) obtained using anatomy-based IO were significantly lower than those obtained using GO. Regarding acute toxicity, Grade 2 or worse acute GU toxicity developed in 23% of all patients, but was significantly lower in patients for whom anatomy-based IO (16%) was used than in those for whom GO was used (37%), consistent with the reduced urethral dose (p < 0.01). Conclusion: The results of this study suggest that anatomy-based 10 is superior to GO for dose optimization in HDR brachytherapy for prostate cancer. (c) 2006 Elsevier Inc.
引用
收藏
页码:1360 / 1366
页数:7
相关论文
共 50 条
  • [41] Anatomy-based definition of point A utilizing three-dimensional volumetric imaging approach for high-dose-rate (HDR) intracavitary brachytherapy dose prescription when treating cervical cancer using limited resources
    Goyal, Manish K.
    Rai, D. V.
    Kehwar, Than S.
    Manjhi, Jayanand
    Heintz, Bret H.
    Shide, Kathleen L.
    Barker, Jerry L.
    [J]. JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 2016, 17 (06): : 69 - 77
  • [42] Nationwide multi-institutional retrospective analysis of high-dose-rate brachytherapy combined with external beam radiotherapy for localized prostate cancer: An Asian Prostate HDR-BT Consortium
    Ishiyama, Hiromichi
    Kamitani, Nobuhiko
    Kawamura, Hidemasa
    Kato, Shingo
    Aoki, Manabu
    Kariya, Shinji
    Matsumura, Taisei
    Kaidu, Motoki
    Yoshida, Ken
    Hashimoto, Yaichiro
    Noda, Yasutaka
    Lim, Keith H. C.
    Kawase, Takatsugu
    Takahashi, Takeo
    Inaba, Koji
    Kumano, Motoyasu
    Yoshikawa, Nobuhiko
    Yoshioka, Yasuo
    Nakamura, Katsumasa
    Hiratsuka, Junichi
    Itami, Jun
    Hayakawa, Kazushige
    [J]. BRACHYTHERAPY, 2017, 16 (03) : 503 - 510
  • [43] Correlation between the changes in the EPIC QOL scores and the dose-volume histogram parameters in high-dose-rate brachytherapy combined with hypofractionated external beam radiation therapy for prostate cancer
    Hashimoto, Yaichiro
    Akimoto, Tetsuo
    Iizuka, Jumpei
    Tanabe, Kazunari
    Mitsuhashi, Norio
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2015, 45 (01) : 81 - 87
  • [44] HYPOFRACTIONATED EXTERNAL BEAM RADIOTHERAPY PLUS HIGH-DOSE-RATE BRACHYTHERAPY FOR INTERMEDIATE OR HIGH RISK PROSTATE CANCER: ANALYSIS OF MEDIUM-TERM URINARY TOXICITY PRECEPTIVE FACTORS AND BIOCHEMICAL CONTROL
    Pellizzon, A. C. A.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S284 - S284
  • [45] Comparison of the outcome and morbidity for localized or locally advanced prostate cancer treated by high-dose-rate brachytherapy plus external beam radiotherapy (EBRT) versus EBRT alone
    Fang, Fu-Min
    Wang, Yu-Ming
    Wang, Chong-Jong
    Huang, Hsuan-Ying
    Chiang, Po-Hui
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2008, 38 (07) : 474 - 479
  • [46] Health-related Quality of Life and Toxicity After Single-fraction High-dose-rate Brachytherapy With External Beam Radiotherapy for Localized and Locally Advanced Prostate Cancer
    Makino, Tomoyuki
    Nakashima, Kazufumi
    Iijima, Masashi
    Kawaguchi, Shouhei
    Nohara, Takahiro
    Shigehara, Kazuyoshi
    Izumi, Kouji
    Kadono, Yoshifumi
    Kumano, Tomoyasu
    Mizokami, Atsushi
    [J]. ANTICANCER RESEARCH, 2019, 39 (01) : 477 - 486
  • [47] Toxicity and clinical outcomes of single-fraction high-dose-rate brachytherapy combined with external beam radiotherapy for high-/very high-risk prostate cancer: A dosimetric analysis of toxicity
    Sakurai, Takayuki
    Takamatsu, Shigeyuki
    Shibata, Satoshi
    Iwata, Koji
    Taka, Masashi
    Gabata, Toshifumi
    Kumano, Tomoyasu
    Makino, Tomoyuki
    Mizokami, Atsushi
    [J]. JAPANESE JOURNAL OF RADIOLOGY, 2020, 38 (12) : 1197 - 1208
  • [48] Toxicity and clinical outcomes of single-fraction high-dose-rate brachytherapy combined with external beam radiotherapy for high-/very high-risk prostate cancer: A dosimetric analysis of toxicity
    Takayuki Sakurai
    Shigeyuki Takamatsu
    Satoshi Shibata
    Koji Iwata
    Masashi Taka
    Toshifumi Gabata
    Tomoyasu Kumano
    Tomoyuki Makino
    Atsushi Mizokami
    [J]. Japanese Journal of Radiology, 2020, 38 : 1197 - 1208
  • [49] Ten Year Survival and Quality of Life after Combined High-Dose-Rate Brachytherapy Boost (HDR-BT) and External Beam Radiotherapy (EBRT) for Localized Prostate Cancer
    Kirste, S.
    Wiedenmann, N.
    Henne, K.
    Bruggmoser, G.
    Knippen, S.
    Volegova, N.
    Schultze-Seemann, W.
    Heinemann, F.
    Grosu, A. L.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S374 - S374
  • [50] PROSPECTIVE MEASUREMENT OF ACUTE TOXICITY DURING PELVIC EXTERNAL BEAM RADIOTHERAPY AND HIGH DOSE RATE (HDR) BRACHYTHERAPY BOOST IN MEN WITH LOCALIZED PROSTATE CANCER STRATIFIED BY AGE
    Galalae, R.
    Tharavichitkul, E.
    Geiger, F.
    Lembke, I.
    Buschbeck, B.
    Kimmig, B.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S338 - S338